Dustin John Rabideau, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 24 | 2023 | 5130 | 0.920 |
Why?
|
Models, Statistical | 2 | 2024 | 5098 | 0.590 |
Why?
|
Research Design | 2 | 2021 | 6210 | 0.490 |
Why?
|
Lithium | 6 | 2019 | 600 | 0.460 |
Why?
|
Lithium Compounds | 8 | 2017 | 226 | 0.440 |
Why?
|
Cluster Analysis | 3 | 2024 | 2721 | 0.370 |
Why?
|
Antimanic Agents | 6 | 2016 | 524 | 0.340 |
Why?
|
Comparative Effectiveness Research | 7 | 2018 | 713 | 0.320 |
Why?
|
Antipsychotic Agents | 10 | 2018 | 3078 | 0.310 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2006 | 0.290 |
Why?
|
Random Allocation | 2 | 2021 | 2394 | 0.270 |
Why?
|
HIV Infections | 6 | 2024 | 17542 | 0.260 |
Why?
|
Models, Theoretical | 1 | 2017 | 3561 | 0.250 |
Why?
|
Confidence Intervals | 2 | 2021 | 2920 | 0.240 |
Why?
|
Implosive Therapy | 1 | 2023 | 127 | 0.200 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2024 | 10393 | 0.200 |
Why?
|
Data Interpretation, Statistical | 2 | 2024 | 2698 | 0.200 |
Why?
|
HIV Integrase Inhibitors | 1 | 2022 | 165 | 0.180 |
Why?
|
Continuity of Patient Care | 2 | 2017 | 1078 | 0.170 |
Why?
|
Ventricular Remodeling | 2 | 2018 | 1281 | 0.170 |
Why?
|
Hyperlipidemias | 2 | 2014 | 771 | 0.160 |
Why?
|
Psychotherapy, Group | 1 | 2022 | 417 | 0.160 |
Why?
|
Behavior Therapy | 1 | 2024 | 886 | 0.150 |
Why?
|
Refugees | 2 | 2017 | 615 | 0.150 |
Why?
|
Benzodiazepines | 2 | 2015 | 1137 | 0.150 |
Why?
|
Quality of Life | 12 | 2024 | 13485 | 0.150 |
Why?
|
Affect | 5 | 2021 | 1494 | 0.150 |
Why?
|
Sample Size | 1 | 2021 | 845 | 0.150 |
Why?
|
Suicidal Ideation | 2 | 2019 | 1467 | 0.140 |
Why?
|
Alkynes | 1 | 2017 | 326 | 0.140 |
Why?
|
Outpatients | 4 | 2023 | 1600 | 0.130 |
Why?
|
Heart Failure, Systolic | 1 | 2018 | 134 | 0.130 |
Why?
|
Dyspnea | 1 | 2024 | 1352 | 0.130 |
Why?
|
Cyclopropanes | 1 | 2017 | 436 | 0.130 |
Why?
|
Severity of Illness Index | 8 | 2018 | 15925 | 0.130 |
Why?
|
Stroke Volume | 4 | 2018 | 5618 | 0.130 |
Why?
|
Benzoxazines | 1 | 2017 | 320 | 0.130 |
Why?
|
Self Report | 3 | 2017 | 3773 | 0.130 |
Why?
|
Antidepressive Agents | 3 | 2017 | 2912 | 0.120 |
Why?
|
Public Sector | 1 | 2017 | 266 | 0.120 |
Why?
|
Financing, Personal | 1 | 2017 | 310 | 0.120 |
Why?
|
Drug Substitution | 1 | 2017 | 292 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13491 | 0.120 |
Why?
|
Anxiety Disorders | 4 | 2021 | 2745 | 0.120 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2018 | 6023 | 0.120 |
Why?
|
Nurses | 1 | 2024 | 2501 | 0.120 |
Why?
|
Suicide | 2 | 2015 | 1606 | 0.120 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2017 | 620 | 0.110 |
Why?
|
Humans | 48 | 2024 | 767040 | 0.110 |
Why?
|
Anti-HIV Agents | 2 | 2022 | 4567 | 0.110 |
Why?
|
Medication Adherence | 2 | 2017 | 2191 | 0.110 |
Why?
|
Terminal Care | 2 | 2024 | 1770 | 0.110 |
Why?
|
Psychological Tests | 1 | 2015 | 642 | 0.110 |
Why?
|
Lithium Chloride | 1 | 2013 | 83 | 0.110 |
Why?
|
Resilience, Psychological | 1 | 2021 | 807 | 0.110 |
Why?
|
Patient Identification Systems | 1 | 2013 | 75 | 0.110 |
Why?
|
Palliative Care | 2 | 2024 | 3641 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1243 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2024 | 3049 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1907 | 0.090 |
Why?
|
Female | 36 | 2024 | 396660 | 0.090 |
Why?
|
Ambulatory Care Facilities | 1 | 2017 | 939 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 2016 | 812 | 0.090 |
Why?
|
Computer Simulation | 1 | 2024 | 6260 | 0.090 |
Why?
|
Cost of Illness | 2 | 2021 | 1951 | 0.090 |
Why?
|
Attitude | 1 | 2015 | 769 | 0.080 |
Why?
|
Uganda | 3 | 2022 | 1353 | 0.080 |
Why?
|
Treatment Outcome | 15 | 2023 | 65295 | 0.080 |
Why?
|
Middle Aged | 26 | 2024 | 223233 | 0.080 |
Why?
|
Male | 34 | 2024 | 364203 | 0.080 |
Why?
|
Heart Failure | 4 | 2018 | 11877 | 0.080 |
Why?
|
Health Services Research | 1 | 2017 | 1815 | 0.080 |
Why?
|
Adult | 27 | 2022 | 223317 | 0.080 |
Why?
|
Disability Evaluation | 1 | 2016 | 1829 | 0.080 |
Why?
|
Anxiety | 2 | 2022 | 4670 | 0.080 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1749 | 0.070 |
Why?
|
Comorbidity | 6 | 2019 | 10582 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2018 | 2144 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2017 | 2232 | 0.070 |
Why?
|
Attitude to Health | 1 | 2015 | 2023 | 0.070 |
Why?
|
Ambulatory Care | 2 | 2015 | 2780 | 0.060 |
Why?
|
Psychotherapy | 1 | 2015 | 1653 | 0.060 |
Why?
|
Counseling | 1 | 2013 | 1553 | 0.060 |
Why?
|
Heart Rate | 1 | 2017 | 4209 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2023 | 4629 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2017 | 1987 | 0.060 |
Why?
|
Psychotic Disorders | 2 | 2017 | 3275 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5716 | 0.060 |
Why?
|
South Africa | 2 | 2022 | 1873 | 0.060 |
Why?
|
Young Adult | 11 | 2019 | 59980 | 0.060 |
Why?
|
Electrocardiography | 1 | 2017 | 6409 | 0.060 |
Why?
|
Treatment Failure | 2 | 2022 | 2658 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2016 | 5141 | 0.050 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2013 | 1495 | 0.050 |
Why?
|
Dibenzothiazepines | 2 | 2014 | 102 | 0.050 |
Why?
|
Decision Making | 2 | 2016 | 3951 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15645 | 0.050 |
Why?
|
Aged | 13 | 2024 | 171319 | 0.050 |
Why?
|
Exercise | 2 | 2022 | 5954 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26325 | 0.050 |
Why?
|
MicroRNAs | 1 | 2018 | 3792 | 0.050 |
Why?
|
Adaptation, Psychological | 2 | 2024 | 2662 | 0.050 |
Why?
|
Overweight | 1 | 2013 | 2448 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 3236 | 0.050 |
Why?
|
Viral Load | 2 | 2022 | 3385 | 0.040 |
Why?
|
Choice Behavior | 2 | 2017 | 848 | 0.040 |
Why?
|
Mass Screening | 1 | 2016 | 5456 | 0.040 |
Why?
|
Prospective Studies | 7 | 2023 | 54886 | 0.040 |
Why?
|
Migraine Disorders | 1 | 2013 | 1712 | 0.040 |
Why?
|
Algorithms | 2 | 2017 | 14098 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2013 | 3232 | 0.040 |
Why?
|
Neoplasm Staging | 2 | 2024 | 11217 | 0.040 |
Why?
|
Adolescent | 9 | 2017 | 89046 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4903 | 0.040 |
Why?
|
Psychotropic Drugs | 2 | 2015 | 881 | 0.040 |
Why?
|
Suicide, Attempted | 2 | 2019 | 1413 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 4422 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2022 | 14766 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 9081 | 0.040 |
Why?
|
Asthma | 2 | 2014 | 6268 | 0.040 |
Why?
|
Depression | 2 | 2015 | 8234 | 0.040 |
Why?
|
Dideoxynucleosides | 1 | 2017 | 135 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12536 | 0.030 |
Why?
|
Drug Resistance | 1 | 2022 | 1592 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7469 | 0.030 |
Why?
|
Anti-Anxiety Agents | 1 | 2018 | 405 | 0.030 |
Why?
|
Irritable Mood | 1 | 2017 | 196 | 0.030 |
Why?
|
Psychometrics | 2 | 2015 | 3060 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5886 | 0.030 |
Why?
|
Lamivudine | 1 | 2017 | 367 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2019 | 643 | 0.030 |
Why?
|
Blood Circulation | 1 | 2015 | 248 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2024 | 1444 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 683 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2015 | 281 | 0.030 |
Why?
|
Diuretics | 1 | 2016 | 614 | 0.030 |
Why?
|
Cohort Studies | 4 | 2017 | 41718 | 0.030 |
Why?
|
Personality Inventory | 1 | 2015 | 1018 | 0.030 |
Why?
|
Hypertension | 1 | 2013 | 8615 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2022 | 1787 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 22254 | 0.020 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2018 | 562 | 0.020 |
Why?
|
Drug Combinations | 1 | 2017 | 2086 | 0.020 |
Why?
|
Prevalence | 2 | 2018 | 15851 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8732 | 0.020 |
Why?
|
Eosinophils | 1 | 2015 | 951 | 0.020 |
Why?
|
Internet | 1 | 2022 | 3114 | 0.020 |
Why?
|
Disease Progression | 2 | 2018 | 13646 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12069 | 0.020 |
Why?
|
Employment | 1 | 2016 | 1110 | 0.020 |
Why?
|
RNA, Viral | 1 | 2017 | 2867 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6215 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2227 | 0.020 |
Why?
|
Allergens | 1 | 2015 | 1436 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2013 | 963 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6331 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4855 | 0.020 |
Why?
|
Prescription Drugs | 1 | 2013 | 635 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2021 | 4526 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10748 | 0.020 |
Why?
|
Caregivers | 1 | 2017 | 2302 | 0.010 |
Why?
|
Risk Assessment | 2 | 2016 | 24299 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6513 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39317 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3934 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2017 | 3721 | 0.010 |
Why?
|
Risk Factors | 3 | 2016 | 74886 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10092 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5875 | 0.010 |
Why?
|
Hospitals | 1 | 2017 | 3883 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14672 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8535 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2018 | 59548 | 0.010 |
Why?
|
Seizures | 1 | 2014 | 2996 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9362 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8736 | 0.010 |
Why?
|
Mental Health | 1 | 2015 | 3272 | 0.010 |
Why?
|
Child | 2 | 2021 | 80771 | 0.010 |
Why?
|
Obesity | 2 | 2013 | 13085 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13284 | 0.010 |
Why?
|
HIV-1 | 1 | 2017 | 6951 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15424 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 7868 | 0.010 |
Why?
|
United States | 2 | 2018 | 72971 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20169 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7435 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18401 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29963 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 13048 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 40154 | 0.010 |
Why?
|
Neoplasms | 1 | 2014 | 22350 | 0.000 |
Why?
|